The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening

Proteins
Gordon WellsStephen F Traynelis

Abstract

N-methyl-D-aspartate (NMDA) receptors are transmembrane glutamate-binding ion channels that mediate neurotransmission in mammals. NMDA receptor subunits are tetrameric complexes of GluN1 and GluN2A-D subunits, encoded by the GRIN gene family. Of these subunits, GluN2B is suggested to be required for normal development of the central nervous system. A mutation identified in a patient with developmental delay, E413G, resides in the GluN2B ligand-binding domain and substantially reduces glutamate potency by an unknown mechanism. GluN2B Gly413, though near the agonist, is not in van der Waals contact with glutamate. Visual analysis of the GluN2B structure with the E413G mutation modeled suggests that replacement of Glu with Gly at this position increases solvent access to the ligand-binding domain. This was confirmed by molecular modeling, which showed that the ligand is more mobile in GluN2B-E413G than WT GluN2B. Evaluation of agonist occupancy using random accelerated molecular dynamics (RAMD) simulations predicts that the glutamate exits the binding-site more rapidly for GluN2B-E413G than WT receptors. This analysis was extended to other binding-site mutations, which produced qualitative agreement between experimentally determin...Continue Reading

References

Jan 1, 1985·Progress in Biophysics and Molecular Biology·W G Hol
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Jun 10, 2000·Science·C J Woolf, M W Salter
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter J WinnRebecca C Wade
Jun 21, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kathleen A HabernyWilliam Slikker
Dec 20, 2003·Annals of the New York Academy of Sciences·Joseph T CoyleDonald Goff
Mar 30, 2004·Proteins·Matthew P JacobsonRichard A Friesner
May 28, 2004·Pharmacology & Therapeutics·Penelope J Hallett, David G Standaert
Jan 22, 2005·Current Opinion in Pharmacology·Brian J MorrisJudith A Pratt
Jul 20, 2005·EMBO Reports·Karin SchleinkoferRebecca C Wade
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Nov 11, 2005·Nature·Hiroyasu FurukawaEric Gouaux
Mar 10, 2006·Organic & Biomolecular Chemistry·Ulla PentikäinenOlli T Pentikäinen
Jun 24, 2006·BMC Bioinformatics·Martin PetrekJirí Damborský
Jul 19, 2008·Lancet Neurology·Lorraine V KaliaMichael W Salter
Sep 10, 2009·Neuropharmacology·Pekka A PostilaOlli T Pentikäinen
Nov 17, 2009·The EMBO Journal·Erkan KarakasHiro Furukawa
Dec 1, 2009·Nature·Alexander I SobolevskyEric Gouaux
Feb 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shashank M DravidStephen F Traynelis
Jun 22, 2010·The Journal of Physical Chemistry. B·Lu Tian LiuPei Tang
Jul 28, 2010·Molecular Pharmacology·Kasper B HansenStephen F Traynelis
Aug 19, 2010·Pharmacological Reviews·Stephen F TraynelisRay Dingledine
Apr 28, 2011·Nature Communications·Katie M VanceHiro Furukawa
Jan 10, 2012·Disease Models & Mechanisms·William A GahlManfred Boehm
Jan 24, 2012·Journal of Chemical Information and Modeling·Subha Kalyaanamoorthy, Yi-Ping Phoebe Chen
Oct 19, 2012·PloS One·Mikko Ylilauri, Olli T Pentikäinen
Nov 14, 2012·Journal of Chemical Information and Modeling·K VanommeslaegheA D MacKerell
Nov 14, 2012·Journal of Chemical Information and Modeling·K Vanommeslaeghe, A D MacKerell
Jan 28, 2014·Neuron·Annie JespersenHiro Furukawa
May 31, 2014·Science·Erkan Karakas, Hiro Furukawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.